Results per Page:
Engineering B cells to improve HIV treatments
From the Kiem lab, Translational Sciences and Therapeutics Division
A tale of two T-cells: comparing liso-cel and axi-cel for treatment of refractory large B-cell lymphoma
From the Gauthier group, Clinical Research Division
Try before you buy: a new method for validating antigen probes used in B and T cell research
From the Taylor Lab, Vaccine and Infectious Disease Division
Work smarter not harder: Leveraging cancer immunotherapies to improve organ transplantation
From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
B cell kinetics during HSV-2 infection
From the Corey lab, Vaccine and Infectious Disease Division
Your vote needed! Hutch science competes in 'STAT Madness'
Studies by Drs. Justin Taylor, Robert Bradley are finalists in annual competition for best biomedical advance
Fine-tuning B cell responses
From the Taylor Lab, Vaccine and Infectious Disease Division
Engineering B cells to bypass vaccines
From the Taylor Lab, Vaccine and Infectious Disease Division
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
BCR or biomarker?
From the Warren laboratory, Clinical Research Division and Vaccine and Infectious Disease Division
New approach aims to restore immune-powering B cells in cancer patients following successful immunotherapy with CAR T cells
New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy
Applicants wanted: Most inclusive fellowship program among top cancer centers
New fellowships created to support scientists from underrepresented groups, attract more top minds to Fred Hutch